Asofarma de México S.A de C.V.   Report issue

For profit Phase 1 Phase 3
Founded: Mexico (1988)
Status: No NME R&D (1988)

Organization Overview

First Clinical Trial
2012
NCT02726269
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Asofarma S.A.I. y C.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Gastritis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 7